← Open Payments lookup

CARRIE FOXWORTH: Open Payments

NPI 1972018992 · LAUREL, MS. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$1,448 in 71 payments from 12 companies in 2025. Trend: 2023 $1,492 · 2024 $1,387 · 2025 $1,448

Food & beverage: $1,448
CompanyPaymentsAmount
ABBVIE INC.15$250
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)13$215
Lundbeck LLC9$196
Neurocrine BioSciences, Inc.4$142
Vanda Pharmaceuticals Inc.5$115
Teva Pharmaceuticals USA, Inc.5$112
Otsuka America Pharmaceutical, Inc.4$101
E.R. Squibb & Sons, L.L.C.4$79
Supernus Pharmaceuticals, Inc.4$74
Janssen Pharmaceuticals, Inc3$71

Products named: VRAYLAR, CAPLYTA, REXULTI, INGREZZA, FANAPT, AUSTEDO XR, COBENFY, Qelbree.

Industry payments across MS — which companies pay providers there.